Table 3. Multiple regression model predicting adipose tissue PTX3 mRNA in 56 patients with CKD stage 5.
Adjusted r2 = 0.27; p = 0.002 | |||
Variable | Beta | Standard Error | p-value |
Age | −0.27 | 0.3 | 0.04 |
Sex (reference: male) | 0.05 | 6.2 | 0.67 |
Diabetes mellitus (ref: no diabetes) | |||
Type 1 diabetes mellitus | −0.06 | 8.9 | 0.63 |
Type 2 diabetes mellitus | 0.08 | 8.6 | 0.59 |
PTX3 (ng/ml) 1-SD increase | 0.31 | 3.3 | 0.02 |
ADMA (µmol/l) 1-SD increase | 0.36 | 7.9 | 0.004 |
ADMA, asymmetric dimethylarginine; CKD, chronic kidney disease; PTX3, pentraxin 3. Variables PTX3 and ADMA were expressed as 1-standard deviation (1-SD) increase.